ESSA PHARMA
ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.
ESSA PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.essapharma.com
Total Employee:
11+
Status:
Active
Contact:
(832) 831-5958
Email Addresses:
[email protected]
Total Funding:
280.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-05-16 | Realm Therapeutics | Realm Therapeutics acquired by ESSA Pharma | N/A |
Investors List
BVF Partners
BVF Partners investment in Post-IPO Equity - ESSA Pharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - ESSA Pharma
Pfizer Breakthrough Growth Initiative
Pfizer Breakthrough Growth Initiative investment in Post-IPO Equity - ESSA Pharma
Vivo Capital
Vivo Capital investment in Post-IPO Equity - ESSA Pharma
CAM Capital
CAM Capital investment in Post-IPO Equity - ESSA Pharma
Avidity Partners
Avidity Partners investment in Post-IPO Equity - ESSA Pharma
Ridgeback Capital
Ridgeback Capital investment in Post-IPO Equity - ESSA Pharma
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - ESSA Pharma
Pfizer
Pfizer investment in Post-IPO Equity - ESSA Pharma
Point72
Point72 investment in Post-IPO Equity - ESSA Pharma
Official Site Inspections
http://www.essapharma.com Semrush global rank: 8.76 M Semrush visits lastest month: 261
- Host name: 37.115.215.35.bc.googleusercontent.com
- IP address: 35.215.115.37
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043